These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15173893)

  • 1. Neurobiology of severe mental disorders: from cell to bedside 25th International Symposium of the Centre de recherche en sciences neurologiques, Université de Montréal.
    Rompré PP; Stip E; Trudeau LE
    J Psychiatry Neurosci; 2004 May; 29(3):167-9. PubMed ID: 15173893
    [No Abstract]   [Full Text] [Related]  

  • 2. Spatial representations and sensorimotor transformations. The IXth International Symposium of the Centre de Recherche en Sciences Neurologiques, Université de Montréal. Montréal (Québec), May 28-29, 1987. Proceedings.
    Can J Physiol Pharmacol; 1988 Apr; 66(4):427-539. PubMed ID: 3167676
    [No Abstract]   [Full Text] [Related]  

  • 3. Extrapyramidal symptoms with selective serotonin reuptake inhibitors.
    Arya DK
    Br J Psychiatry; 1994 Dec; 165(6):728-33. PubMed ID: 7881774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
    Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
    Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM; Hirschfeld RM; Ninan PT
    Psychopharmacol Bull; 2002; 36 Suppl 2():49-67. PubMed ID: 12490823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors (SSRIs) in children and adolescents.
    Vitiello B
    J Child Adolesc Psychopharmacol; 2006; 16(1-2):7-9. PubMed ID: 16553524
    [No Abstract]   [Full Text] [Related]  

  • 7. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
    Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
    Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic clinical Interview for Drug Withdrawal 1 (DID-W1) – New Symptoms of Selective Serotonin Reuptake Inhibitors (SSRI) or Serotonin Norepinephrine Reuptake Inhibitors (SNRI): inter-rater reliability.
    Cosci F; Chouinard G; Chouinard VA; Fava GA
    Riv Psichiatr; 2018; 53(2):95-99. PubMed ID: 29674777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporters.
    Inoue T; Kusumi I; Yoshioka M
    Curr Drug Targets CNS Neurol Disord; 2002 Oct; 1(5):519-29. PubMed ID: 12769604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of psychopathology. The low-norepinephrine and low-serotonin rat.
    Ellison GD
    Am Psychol; 1977 Dec; 32(12):1036-45. PubMed ID: 563690
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience is a biochemical intervention: reconceptualizing the "biologically based mental illness".
    Seidel JA
    Bull Menninger Clin; 2005; 69(2):157-71. PubMed ID: 16006250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 5-HT1A receptors: from molecular biology to neuropsychiatric symptoms].
    Navinés R; Gómez E; Gastó C
    Actas Esp Psiquiatr; 2003; 31(5):272-83. PubMed ID: 14557952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin research: Crossing scales and boundaries.
    Di Giovanni G; De Deurwaerdère P
    Neuropharmacology; 2020 Dec; 181():108340. PubMed ID: 33007358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
    Hornykiewicz O
    J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular mechanisms of psychiatric diseases.
    Blokhin IO; Khorkova O; Saveanu RV; Wahlestedt C
    Neurobiol Dis; 2020 Dec; 146():105136. PubMed ID: 33080337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies.
    Frazer A
    J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging of individual behaviour.
    Moresco RM; Fazio F
    Eur J Nucl Med Mol Imaging; 2005 Jun; 32(6):717-9. PubMed ID: 15864581
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation.
    Koren G; Ornoy A
    Pharmacogenomics; 2018 Sep; 19(14):1139-1145. PubMed ID: 30105921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain tryptophan perturbation in hepatic encephalopathy: implications for effects by neuropsychoactive drugs in clinical practice.
    Bengtsson F; Bergqvist PB; Apelqvist G
    Adv Exp Med Biol; 1997; 420():1-33. PubMed ID: 9286423
    [No Abstract]   [Full Text] [Related]  

  • 20. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.